Gallium Arsenide Selectively Up-Regulates Inflammatory Cytokine Expression at Exposure Site

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 3, 2003, Pages 1045-1053

  Becker, Stephen M ^a   McCoy, Kathleen L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GALLIUM ARSENIDE; LATEX; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXPOSURE; FEMALE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PERITONEAL FLUID; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY;

ANIMALS; ANTIBODIES, MONOCLONAL; ARSENICALS; B-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GALLIUM; LEUKOCYTES; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; NUCLEASE PROTECTION ASSAYS; RNA, MESSENGER; UP-REGULATION;

EID: 0345167202     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.057919     Document Type: Article

References (31)

1. Bogdan C and Nathan C (1993) Modulation of macrophage function by transforming growth factor beta, interleukin-4 and interleukin-10. Ann NY Acad Sci 685:713-739.
2. Bonnefoy JY, Denoroy MC, Guillot O, Martens CL, and Banchereau J (1989) Activation of normal human B cells through their antigen receptor induces membrane expression of IL-1 alpha and secretion of IL-1 beta. J Immunol 143:864-869.
3. Burns LA, Sikorski EE, Saady JJ, and Munson AE (1991) Evidence for arsenic as the immunosuppressive component of gallium arsenide. Toxicol Appl Pharmacol 110:157-169.
4. Caffrey-Nolan RE and McCoy KL (1998) Direct exposure to gallium arsenide up-regulates costimulatory activity of murine macrophages. Toxicol Appl Pharmacol 151:330-339.
5. Fenton MJ, Clark BD, Collins KL, Webb AC, Rich A, and Auron PE (1987) Transcriptional regulation of the human prointerleukin 1 beta gene. J Immunol 138:3972-3979.
6. Fenton MJ, Vermeulen MW, Clark BD, Webb AC, and Auron PE (1988) Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. J Immunol 140:2267-2273.
7. Ferreira KS, Almeida SR, Ribeiro CH, Mariano M, and Lopes JD (2003) Modulation of proliferation, differentiation and cytokine secretion of murine B-1 B cells by proteins of the extracellular matrix. Immunol Lett 86:15-21.
8. 2 by phosphorylation in rat mesangial cells. J Clin Investig 93:1224-1233.
9. Harrison MT, Hartmann CB, and McCoy KL (2003) Impact of in vitro gallium arsenide exposure on macrophages. Toxicol Appl Pharmacol 186:18-27.
10. Harrison MT and McCoy KL (2001) Immunosuppression by arsenic: a comparison of cathepsin L inhibition and apoptosis. Int Immunopharmacol 1:647-656.
11. Harrison RJ (1986) Gallium arsenide: state of the art reviews. Occup Med 1:49-58.
12. Hartmann CB and McCoy KL (1996) Gallium arsenide augments antigen processing by peritoneal macrophages for CD4+ helper T cell stimulation. Toxicol Appl Pharmacol 141:365-372.
13. Kabel PJ, de Haan-Meulman M, Voorbij HA, Kleingeld M, Knol EF, and Drexhage HA (1989) Accessory cells with a morphology and marker pattern of dendritic cells can be obtained from elutriator-purified blood monocyte fractions. An enhancing effect of metrizamide in this differentiation. Immunobiology 179:395-441.
14. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, and Maeda N (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 94:12053-12058.
15. Lewis TA, Hartmann CB, and McCoy KL (1998a) Gallium arsenide differentially affects processing of phagolysosomal targeted antigen by macrophages. J Leukoc Biol 63:321-330.
16. Lewis TA, Hartmann CB, and McCoy KL (1998b) Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages. J Immunol 161:2151-2157.
17. Lewis TA, Munson AE, and McCoy KL (1996) Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation. J Pharmacol Exp Ther 278:1244-1251.
18. Luster MI, Portier C, Pait DG, White KL, Jennings C, Munson AE, and Rosenthal GJ (1992) Risk assessment in immunotoxicity I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol 18:200-210.
19. Nakanishi K, Yoshimoto T, Tsutsui H, and Okamura H (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423-474.
20. National Toxicology Program (2000) NTP technical report on the toxicology and carcinogenesis studies of gallium arsenide (CAS No. 1303-00-0) in F344/N rats and B6C3F1 mice (inhalation studies). NTP-TR492/National Institutes of Health Publication No. 00-3951, NIH, Bethesda, MD.
21. Schramm R, Liu Q, and Thorlacius H (2000) Expression and function of MIP-2 are reduced by dexamethasone treatment in vivo. Br J Pharmacol 131:328-334.
22. Schramm R, Schaefer T, Menger MD, and Thorlacius H (2002) Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone. J Leukoc Biol 72:1122-1132.
23. Siebert H, Sachse A, Kuziel WA, Maeda N, and Bruck W (2000) The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol 110:177-185.
24. Sikorski EE, Burns LA, McCoy KL, Stern ML, and Munson AE (1991a) Suppression of splenic accessory cell function in mice exposed to gallium arsenide. Toxicol Appl Pharmacol 110:143-156.
25. Sikorski EE, Burns LA, Stern ML, Luster MI, and Munson AE (1991b) Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response. Toxicol Appl Pharmacol 110:129-142.
26. Sikorski EE, McCay JA, White KL, Bradley SG, and Munson AE (1989) Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundam Appl Toxicol 13:843-858.
27. Tanaka A, Hirata M, Omura M, Zhao M, Makita Y, Yamazaki K, Inoue N, Gotoh K (2000) Comparative study of the toxic effects of gallium arsenide, indium arsenide and arsenic trioxide following intratracheal instillations to the lung of Syrian golden hamsters. Fukuoka Igaku Zasshi 91:21-33.
28. 2-responses by rat alveolar macrophages. Am J Pathol 130:489-495.
29. Webb DR, Wilson SE, and Carter DE (1986) Comparative pulmonary toxicity of gallium arsenide, gallium (III) oxide, or arsenic (III) oxide intratracheally instilled into rats. Toxicol Appl Pharmacol 82:405-416.
30. World Health Organization (1992) Inorganic arsenic compounds other than arsine. WHO Health and Safety Guide No. 70, Geneva.
31. Zhou LJ and Tedder TF (1996) CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 93:2588-2592.